128 related articles for article (PubMed ID: 37734252)
1. Multi-omics analysis reveals the mechanism of action of ophiopogonin D against pulmonary fibrosis.
Bao S; Chen T; Chen J; Zhang J; Zhang G; Hui Y; Li J; Yan S
Phytomedicine; 2023 Dec; 121():155078. PubMed ID: 37734252
[TBL] [Abstract][Full Text] [Related]
2. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
3. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
5. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
Ruan H; Gao S; Li S; Luan J; Jiang Q; Li X; Yin H; Zhou H; Yang C
Molecules; 2021 May; 26(9):. PubMed ID: 34068694
[TBL] [Abstract][Full Text] [Related]
6. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
[TBL] [Abstract][Full Text] [Related]
7. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
8. Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway.
Pei X; Zheng F; Li Y; Lin Z; Han X; Feng Y; Tian Z; Ren D; Cao K; Li C
Cells; 2022 Jan; 11(3):. PubMed ID: 35159160
[TBL] [Abstract][Full Text] [Related]
9. Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice.
Pan L; Cheng Y; Yang W; Wu X; Zhu H; Hu M; Zhang Y; Zhang M
Inflammation; 2023 Aug; 46(4):1531-1542. PubMed ID: 37160579
[TBL] [Abstract][Full Text] [Related]
10. Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.
Li X; Ma X; Miao Y; Zhang J; Xi B; Li W; Zhang Q; Chen L; Yang Y; Li H; Wei L; Zhou H; Yang C
J Cell Mol Med; 2023 Feb; 27(3):422-434. PubMed ID: 36651446
[TBL] [Abstract][Full Text] [Related]
11. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
12. Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.
Fang L; Chen H; Kong R; Que J
Life Sci; 2020 Nov; 260():118399. PubMed ID: 32918977
[TBL] [Abstract][Full Text] [Related]
13. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway.
Yin JZ; Li ZQ; Zhang XD; Wan ZJ; Qin HR; Yao LH; Li BL; Gao F; Yang YY
Eur J Pharmacol; 2024 Feb; 964():176293. PubMed ID: 38158113
[TBL] [Abstract][Full Text] [Related]
14. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
[TBL] [Abstract][Full Text] [Related]
15. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway.
Miao Y; Li X; Yang Y; Zhang J; Chen L; Zhang Q; Li W; Liu Y; Zhang X; Gu R; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt B):109427. PubMed ID: 36375321
[TBL] [Abstract][Full Text] [Related]
16. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.
Ruan H; Luan J; Gao S; Li S; Jiang Q; Liu R; Liang Q; Zhang R; Zhang F; Li X; Zhou H; Yang C
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361644
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
[TBL] [Abstract][Full Text] [Related]
18. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
Nie Y; Zhang D; Qian F; Wu Y
Int Immunopharmacol; 2019 Sep; 74():105696. PubMed ID: 31229901
[TBL] [Abstract][Full Text] [Related]
19. Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.
Li X; Ma L; Huang K; Wei Y; Long S; Liu Q; Zhang D; Wu S; Wang W; Yang G; Zhou H; Yang C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671452
[TBL] [Abstract][Full Text] [Related]
20. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
[Next] [New Search]